ANTIPODES PARTNERS LTD Merck & Co., Inc. Transaction History

ANTIPODES PARTNERS LTD portfolio value:

$195.05M
portfolio value

ANTIPODES PARTNERS LTD quarter portfolio value change:

-5.54%
quarter

Merck & Co., Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +16.24% 316.43K shares 17.41M $86.12 2.26M
Q2 2022 share Decrease -10.93% -239.17K shares -1.85M $91.17 1.94M
Q1 2022 share Increase +11.00% 216.85K shares 18.91M $82.05 2.18M
Q4 2021 share Increase +3.59% 68.27K shares 17.68M $77.14 1.97M
Q3 2021 share Decrease -7.53% -154.94K shares -17.11M $75.11 1.90M
Q2 2021 share Decrease -3.42% -72.93K shares 3.29M $77.08 2.05M
Q1 2021 share Increase +5.36% 108.40K shares -1.11M $72.28 2.13M
Q4 2020 share Increase +11.15% 202.78K shares 13.83M $76.03 2.02M
Q3 2020 share Decrease -8.15% -161.40K shares -2.15M $76.48 1.81M
Q2 2020 share Increase +2.01% 39.09K shares 3.60M $70.79 1.98M
Q1 2020 share Increase 0.00% 1.94M shares 142.53M $69.87 1.94M
Q4 2019 share Decrease -100.00% -1.85M shares -148.86M $81.94 0
Q3 2019 share Increase +20.71% 317.95K shares 26.02M $75.33 1.85M
Q2 2019 share Increase 0.00% 1.53M shares 122.83M $74.54 1.53M